ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

NIH Plans Meeting On Human Subjects Issues In Research

June 30, 1995

In Brief: HEW Clamps Down On Former Employees Hired To Go After Jobs They Had Helped Develop

May 3, 1974

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975